Search clinical trials for: Rivoceranib
Total 16 results
-
Elevar TherapeuticsCompleted
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedAdvanced Hepatocellular Carcinoma (HCC)China
-
Elevar TherapeuticsCompletedMetastatic Colorectal CancerUnited States
-
Elevar TherapeuticsCompletedGastric Cancer | Gastric AdenocarcinomaUnited States, United Kingdom, Korea, Republic of, France, Taiwan, Japan, Russian Federation, Germany, Italy, Poland, Romania, Ukraine
-
Elevar TherapeuticsCompletedAdenoid Cystic CarcinomaUnited States, Korea, Republic of
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingAdjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or AblationChina
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.RecruitingIntrahepatic CholangiocarcinomaChina
-
Samsung Medical CenterNot yet recruitingThymic Epithelial TumorKorea, Republic of
-
Ruijin HospitalRecruiting
-
M.D. Anderson Cancer CenterElevar TherapeuticsNot yet recruitingMetastatic Olfactory Neuroblastoma | Recurrent Olfactory NeuroblastomaUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Jiangsu HengRui Medicine Co., Ltd.CompletedLocally Advanced or Metastatic and Unresectable HCCUnited States, Spain, China, Taiwan, Belgium, Korea, Republic of, Italy, Hong Kong, Russian Federation, Ukraine, Turkey, Poland, Germany
-
Elevar TherapeuticsCompleted
-
Elevar TherapeuticsTerminatedGastric Cancer | Gastroesophageal Junction AdenocarcinomaKorea, Republic of
-
Asan Medical CenterRecruitingGastrointestinal Stromal TumorsKorea, Republic of
-
Boehringer IngelheimCompleted